Seikagaku Growth Driven by U.S. Market Gains

Seikagaku reported FY 3Q19 orthopedic revenue of ¥3,746.2 million (USD $33.8 million), +10.1% vs. 3Q18. The company’s domestic orthobiologic orders fell slightly despite share gains as the overall Japanese viscosupplement market contracted. Domestic revenue grew in the mid-single digits year over year due primarily to the soft comparison....

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us